Daclizumab exhibits efficacy in multiple sclerosis subjects positive for interferon-beta neutralizing antibodies

被引：0
|
作者：
Neyer, Lauri [1 ]
Singer, Robert [1 ]
Wang, Helen [1 ]
Caras, Ingrid [1 ]
机构：
[1] PDL BioPharma, Preclin & Clin Dev Sci, Redwood City, CA USA
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [41] Body mass index and interferon-beta efficacy (and safety) in multiple sclerosis
    Koudriavtseva, Tatiana
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 371 : 79 - 80
  • [42] Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis
    Petkau, J
    White, R
    MULTIPLE SCLEROSIS, 1997, 3 (06): : 402 - 402
  • [43] Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta
    Farrell, R.
    Kapoor, R.
    Leary, S.
    Rudge, P.
    Thompson, A. J.
    Millerand, D. H.
    Giovannoni, G.
    MULTIPLE SCLEROSIS, 2008, 14 (02): : 212 - 218
  • [44] Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
    Sorensen, PS
    Koch-Henriksen, N
    Ross, C
    Clemmesen, KM
    Bendtzen, K
    NEUROLOGY, 2005, 65 (01) : 33 - 39
  • [45] Persistency of neutralizing antibodies depends on titer and interferon-beta preparation
    Hegen, Harald
    Schleiser, Manuel
    Gneiss, Claudia
    Di Pauli, Franziska
    Ehling, Rainer
    Kuenz, Bettina
    Lutterotti, Andreas
    Berger, Thomas
    Deisenhammer, Florian
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (05) : 610 - 615
  • [46] NEUTRALISING ANTIBODIES TO INTERFERON-BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS
    Gafson, Arie
    Worthington, Viki
    Lakdawala, Neghat
    Giovannoni, Gavin
    Farrell, Rachel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [47] Neutralizing antibodies against Interferon-beta in neuromyelitis optica patients
    Asgari, Nasrin
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 27 - 28
  • [48] Persistent neutralising antibodies to interferon-beta and clinical outcomes in multiple sclerosis patients
    Costelloe, L.
    O'Rourke, K.
    Tubridy, N.
    Hutchinson, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S205 - S205
  • [49] Neutralising antibodies to interferon-beta therapy in relapsing multiple sclerosis: a pilot study
    Lau, A. Y. L.
    Chan, E.
    Lau, K. K.
    Mok, V
    Siu, D. Y. W.
    Lee, R.
    HONG KONG MEDICAL JOURNAL, 2019, 25 (04) : 22 - 25
  • [50] Neutralizing antibodies have a higher affinity to interferon-beta than non-neutralizing antibodies
    Tripp, P
    Gneiss, C
    Deisenhammer, F
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 217 - 217
12345